Navigation Links
Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
Date:1/24/2008

RESEARCH TRIANGLE PARK, N.C., Jan. 24 /PRNewswire/ -- Quintiles Transnational Corp. today announced the completion of its previously announced new investor partnership to support the company's continued growth under the leadership of founder and current Chairman and CEO Dennis Gillings, CBE, and the management team. Gillings and global private investment firms Bain Capital and TPG Capital have become the lead investors in Quintiles, with 3i also becoming a significant investor. Temasek Holdings remains an investor in Quintiles. As part of the transaction, One Equity Partners, the private equity arm of JPMorgan Chase (NYSE: JPM), has sold its stake in the company to the new investor partnership. Terms of the transaction were not disclosed. The company incurred no new debt as a result of the deal.

About Quintiles Transnational

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the pharmaceutical, biotechnology and healthcare industries. With about 20,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's web site at http://www.qtrn.com.

About Bain Capital

Bain Capital (http://www.baincapital.com) is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1
'/>"/>

SOURCE Quintiles Transnational Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Quintiles to Open Clinical Research Office in Wilmington, NC
2. Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
3. Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
4. Expert Cardiologist Joins Quintiles Medical Group
5. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
6. CNS Response, Inc Completes Neuro-Therapy Clinic Acquisition; Names Daniel A. Hoffman, MD Chief Medical Officer
7. Abington Memorial Hospital Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
8. China Medical Technologies Completes Acquisition of BBE
9. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
10. Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
11. Pharmos Corporation Completes Initial Closing of Private Placement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009).../PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),...unced today that it executed,a joint venture (JV) ...chnology Co., Ltd. (Sinovac Dalian). The JV will r...use vaccines. Sinovac will contribute its expertis... world-class vaccines; the,other party will bring ...
(Date:11/24/2009)...also Visit Detroit , (Voc...ench Ambassador for International Investment, and ... , , ,What: Ambassador Appia is available to meet...ives adopted by France to further develop the fina...n and development., , ,When: Available for Intervi...
(Date:11/24/2009)...swire-FirstCall/ -- Sigma-Aldrich Corporation (Nas...conference on Tuesday, December 1st at 1:45 PM GMT... listen via live audio broadcast over the Internet...ldrich.com/ . Users can click the "Webcast" icon...h: Sigma-Aldrich is a leading Life Science and H...
(Date:11/24/2009)...PRNewswire-Asia/ -- Shanghai Biolaxy announced the...A) has approved the,investigational new drug appli..., an innovative insulin formulation to treat diabe...its first phase I clinical study. , Diabe...cose and poor,metabolism. The complications of dia...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
...2 Bavarian Nordic, the,Danish-based biopharmaceut...eport. Below is an extract of the most significant... balance sheet date., Bavarian Nordic,s revenue f... before tax of DKK 50.5 million, which was in line...arian Nordic expects revenue in the region of,DKK ...
...08 Pharmaceutical,companies currently challenged ...pected to go off patent in the next four years mus... success, according to a new report,released by De... Changing Face of R&D in the Future,Pharmaceutical...ma ), current R&D,programs focused on developing a...
..., April 2 Today, (2nd,April 2008), Cyprotex annou...e(R) Select. Cloe(R) Select is a portfolio of besp...customer requirements. It complements the,current ...sorption,distribution, metabolism and excretion) a...through to later stage development projects. As wi...
Other Biology Technology:Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 2Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 3Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 4Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 5Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 6Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 7Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 8Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 9As Billions in Blockbuster Drug Revenue Goes Off Patent, Life Sciences Companies are Challenged to Fundamentally Change Future R&D Strategies, According to New Deloitte Report 2As Billions in Blockbuster Drug Revenue Goes Off Patent, Life Sciences Companies are Challenged to Fundamentally Change Future R&D Strategies, According to New Deloitte Report 3Cyprotex Introduces New Product Line Cloe(R) Select - a Portfolio of Bespoke ADME and PK Services 2
(Date:11/25/2009)...n you eat may be just as vital to your health as w...te for Biological Studies. Their experiments in mi...ousands of genes in the liverthe body,s metabolic ...nd not by the body,s circadian clock as convention... the activity of a large number of genes completel...
(Date:11/24/2009)... opening new doors to understanding how sounds ass...f a marine mammal or if they hear it at all. , ...ners that NASA uses to detect flaws in the space s...ng scientists to peek inside the giant head of a w...sional replicas of a whale,s hearing anatomy using...
(Date:11/24/2009)...action of a remarkable class of ring-shaped protei...e Lawrence Berkeley National Laboratory (Berkeley ...phy beamline at the Advanced Light Source (ALS). T...ression and replication, and are vital to the surv...s agents, such as the human papillomavirus, which ...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4New Reid Bill Funds Abortion 3A Excludes Bipartisan Stupak Pitts Amendment 61737 1New Reid Bill Funds Abortion 3A Excludes Bipartisan Stupak Pitts Amendment 61737 2Esteemed Endorsements Recognize Promising Future of Breast Specific Gamma Imaging 28BSGI 29 6413 1Esteemed Endorsements Recognize Promising Future of Breast Specific Gamma Imaging 28BSGI 29 6413 2Esteemed Endorsements Recognize Promising Future of Breast Specific Gamma Imaging 28BSGI 29 6413 3Moderate Drinking Guards the Heart 61733 1Moderate Drinking Guards the Heart 61733 2Moderate Drinking Guards the Heart 61733 3
...as been shown to improve blood flow in diseased ar...nd heart attacks, a Monash University study publis... development for the Monash team that, in conjunct...as part of a revolution in the management of heart...Centre for Vascular Health and his colleagues at M...
...n to evolution; it allows genetic material from pa...nome. But how did sex itself evolve" Researchers a...ional Laboratory and the University of California ...omplex question in ongoing studies of the nematode...eley Lab,s Life Sciences Division and UC Berkeley,...
...ge of dinosaur discovery is yet upon us, according.... In a forthcoming issue of the Proceedings of th... groundbreaking 1990 census on the diversity of di...ghter outlook about the number of dinosaurs waitin...t dinosaur populations were stable, and not on the...
Other Biology News:Heart smart: new drug improves blood flow 2New clues to how sex evolves 2New clues to how sex evolves 3New clues to how sex evolves 4Good times ahead for dinosaur hunters, according to U of Penn scientist's dinosaur census 2Good times ahead for dinosaur hunters, according to U of Penn scientist's dinosaur census 3
...to Alpha unit with motorized heated lid and skirte...microarrays and chips. The four screw-down points ...sealing force of the motorized lid is set with sof...results. This interchangeable Moto Alpha unit func...
...e factor 15 (KLF15) KLF15 is a Cys2-His2 zinc fin...liver, kidneys, heart, and skeletal muscle. Acces...y produced in rabbits immunized with a synthetic p...th an internal ID of P03590 Reconstitution and St...
Affi-Prep Protein A Support, 25 ml from Bio-Rad
...ard is a new tuning and calibration standard for p...trometry. Accumix is a lyophilized 7-peptide stan...oth tuning and calibration of ion trap (i.e. Finni...ectrometers. Direct infusion of the Accumix pepti...
Biology Products: